ABSTRACT Background Botulinum toxin A (BTX-A) has a variety of uses in medicine. Some
evidence suggests that intracavernosal (ic) BTX-A injection administered in addition to …

Background Some evidence suggests that intracavernosal botulinum toxin A (BTX-A IC)
injections administered in addition to phosphodiesterase type 5 inhibitors (PDE5-Is) or …

Erectile dysfunction (ED) is a highly prevalent condition with a variety of possible risk factors
and/or etiologies. Despite significant advances regarding ED pharmacological …

Registered pharmacological treatments are insufficiently effective for erectile dysfunction
(ED) in around 30% of affected men. Intracavernosal injection (ICI) of ona-and …

Intracavernosal injections of botulinum toxin A (BTX/A ic) may be effective for difficult-to-treat
erectile dysfunction (ED). This is a retrospective case series study of the effectiveness of …

Background There has been recent interest in the use of botulinum neurotoxin (BoNT) in the
field of Andrology, whereby it has been investigated in the treatment of penile retraction and …

OBJECTIVE To evaluate the role of botulinum toxin in treating erectile dysfunction as a novel
treatment strategy avoiding morbid and irreversible surgeries. METHODS A systematic …

Introduction Botulinum toxin type A (BoNT-A) has been used to treat several striated and
smooth muscle disorders. During the past year, human and animal studies conducted in …

Background Erectile dysfunction (ED) is a socioeconomic problem. There are several
options for its management including intra‐cavernosal injection (ICI). Objective To compare …